Higher-order SPOP Assembly Reveals a Basis for Cancer Mutant Dysregulation

Overview

Journal Mol Cell

Publisher Cell Press

Specialty Cell Biology

Date 2023 Jan 24

PMID 36693379

Authors

Matthew J Cuneo

Brian G OFlynn

Yu-Hua Lo

Nafiseh Sabri

Tanja Mittag

Affiliations

Soon will be listed here.

Abstract

The speckle-type POZ protein (SPOP) functions in the Cullin3-RING ubiquitin ligase (CRL3) as a receptor for the recognition of substrates involved in cell growth, survival, and signaling. SPOP mutations have been attributed to the development of many types of cancers, including prostate and endometrial cancers. Prostate cancer mutations localize in the substrate-binding site of the substrate recognition (MATH) domain and reduce or prevent binding. However, most endometrial cancer mutations are dispersed in seemingly inconspicuous solvent-exposed regions of SPOP, offering no clear basis for their cancer-causing and peculiar gain-of-function properties. Herein, we present the first structure of SPOP in its oligomeric form, uncovering several new interfaces important for SPOP self-assembly and normal function. Given that many previously unaccounted-for cancer mutations are localized in these newly identified interfaces, we uncover molecular mechanisms underlying dysregulation of SPOP function, with effects ranging from gross structural changes to enhanced self-association, and heightened stability and activity.

Citing Articles

Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations.

Xie X, Zhang O, Yeo M, Lee C, Tao R, Harry S Nature. 2025; 639(8053):241-249.

PMID: 39939763 PMC: 11882451. DOI: 10.1038/s41586-024-08533-3.

Molecular determinants of condensate composition.

Holehouse A, Alberti S Mol Cell. 2025; 85(2):290-308.

PMID: 39824169 PMC: 11750178. DOI: 10.1016/j.molcel.2024.12.021.

Cellular Function of a Biomolecular Condensate Is Determined by Its Ultrastructure.

Scholl D, Boyd T, Latham A, Salazar A, Khan A, Boeynaems S bioRxiv. 2025; .

PMID: 39763716 PMC: 11703246. DOI: 10.1101/2024.12.27.630454.

A conserved N-terminal motif of CUL3 contributes to assembly and E3 ligase activity of CRL3.

Wang W, Liang L, Dai Z, Zuo P, Yu S, Lu Y Nat Commun. 2024; 15(1):3789.

PMID: 38710693 PMC: 11074293. DOI: 10.1038/s41467-024-48045-2.

Structure and dynamics of a pentameric KCTD5/CUL3/Gβγ E3 ubiquitin ligase complex.

Nguyen D, Rath D, Devost D, Petrin D, Rizk R, Ji A Proc Natl Acad Sci U S A. 2024; 121(17):e2315018121.

PMID: 38625940 PMC: 11047111. DOI: 10.1073/pnas.2315018121.

References

Wai D, Szyszka T, Campbell A, Kwong C, Wilkinson-White L, Silva A . The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators. J Biol Chem. 2018; 293(19):7160-7175. PMC: 5949996. DOI: 10.1074/jbc.RA117.000678. View

Punjani A, Rubinstein J, Fleet D, Brubaker M . cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017; 14(3):290-296. DOI: 10.1038/nmeth.4169. View

Bouchard J, Otero J, Scott D, Szulc E, Martin E, Sabri N . Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol Cell. 2018; 72(1):19-36.e8. PMC: 6179159. DOI: 10.1016/j.molcel.2018.08.027. View

Lawrence M, Stojanov P, Mermel C, Robinson J, Garraway L, Golub T . Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014; 505(7484):495-501. PMC: 4048962. DOI: 10.1038/nature12912. View

Scott D, Rhee D, Duda D, Kelsall I, Olszewski J, Paulo J . Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation. Cell. 2016; 166(5):1198-1214.e24. PMC: 5091668. DOI: 10.1016/j.cell.2016.07.027. View

Pettersen E, Goddard T, Huang C, Meng E, Couch G, Croll T . UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2020; 30(1):70-82. PMC: 7737788. DOI: 10.1002/pro.3943. View

Richardson J, Richardson D . Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci U S A. 2002; 99(5):2754-9. PMC: 122420. DOI: 10.1073/pnas.052706099. View

Clark A, Burleson M . SPOP and cancer: a systematic review. Am J Cancer Res. 2020; 10(3):704-726. PMC: 7136909. View

Geng C, Kaochar S, Li M, Rajapakshe K, Fiskus W, Dong J . SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein. Oncogene. 2017; 36(33):4767-4777. PMC: 5887163. DOI: 10.1038/onc.2017.80. View

10.

Livesey B, Marsh J . The properties of human disease mutations at protein interfaces. PLoS Comput Biol. 2022; 18(2):e1009858. PMC: 8849535. DOI: 10.1371/journal.pcbi.1009858. View

11.

Ohta T, Michel J, Xiong Y . Association with cullin partners protects ROC proteins from proteasome-dependent degradation. Oncogene. 1999; 18(48):6758-66. DOI: 10.1038/sj.onc.1203115. View

12.

Geng C, He B, Xu L, Barbieri C, Eedunuri V, Chew S . Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A. 2013; 110(17):6997-7002. PMC: 3637757. DOI: 10.1073/pnas.1304502110. View

13.

Song Y, Xu Y, Pan C, Yan L, Wang Z, Zhu X . The emerging role of SPOP protein in tumorigenesis and cancer therapy. Mol Cancer. 2020; 19(1):2. PMC: 6942384. DOI: 10.1186/s12943-019-1124-x. View

14.

Huang D, Zhuang M, Ayrault O, Schulman B . Identification of conjugation specificity determinants unmasks vestigial preference for ubiquitin within the NEDD8 E2. Nat Struct Mol Biol. 2008; 15(3):280-7. DOI: 10.1038/nsmb.1387. View

15.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

16.

Geng C, Rajapakshe K, Shah S, Shou J, Eedunuri V, Foley C . Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer. Cancer Res. 2014; 74(19):5631-43. PMC: 4209379. DOI: 10.1158/0008-5472.CAN-14-0476. View

17.

Small E, Eggler A, Mesecar A . Development of an efficient E. coli expression and purification system for a catalytically active, human Cullin3-RINGBox1 protein complex and elucidation of its quaternary structure with Keap1. Biochem Biophys Res Commun. 2010; 400(4):471-5. PMC: 5868348. DOI: 10.1016/j.bbrc.2010.08.062. View

18.

Chen V, Arendall 3rd W, Headd J, Keedy D, Immormino R, Kapral G . MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 1):12-21. PMC: 2803126. DOI: 10.1107/S0907444909042073. View

19.

Dai X, Gan W, Li X, Wang S, Zhang W, Huang L . Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat Med. 2017; 23(9):1063-1071. PMC: 5625299. DOI: 10.1038/nm.4378. View

20.

Zhuang M, Calabrese M, Liu J, Waddell M, Nourse A, Hammel M . Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell. 2009; 36(1):39-50. PMC: 2847577. DOI: 10.1016/j.molcel.2009.09.022. View